Latest developments on risk factors and prophylaxis of thromboembolic disease in obstetrics;Actualités sur les facteurs de risque et la prévention des complications thrombotiques de la grossesse

Gynecologie Obstetrique et Fertilite

Volumn 40, Issue 5, 2012, Pages 301-307

  Chauleur, C ^a   Gris, J C ^c   Seffert, P ^a   Mismetti, P ^b  

^a HÔPITAL NORD   (France)

^b University Jean Monnet of Saint Etienne EA3065   (France)

^c DEPARTMENT OF NEUROLOGY   (France)

Author keywords

Placental vascular complication; Pregnancy; Prophylaxis; Risk factor; Venous thromboembolism

Indexed keywords

BIOLOGICAL FACTOR;

CLINICAL FEATURE; FETUS MORTALITY; HEMOSTASIS; HUMAN; MATERNAL MORBIDITY; MATERNAL MORTALITY; PATIENT CARE; PLACENTA DISORDER; REVIEW; RISK FACTOR; RISK REDUCTION; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

EID: 84861577715     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2012.02.007     Document Type: Article

References (62)

1. G. Bourjeily, M. Paidas, H. Khalil, K. Rosene-Montella, and M. Rodger Pulmonary embolism in pregnancy Lancet. 375 2010 500 512
2. P.E. Marik, and L.A. Plante Venous thromboembolic disease and pregnancy N Engl J Med. 359 2008 2025 2033
3. B. Isermann, R. Sood, R. Pawlinski, M. Zogg, S. Kalloway, and J.L. Degen The thrombomodulin-protein C system is essential for the maintenance of pregnancy Nat Med. 9 2003 331 337
4. Y. Nadir, I. Henig, I. Naroditzky, B. Paz, I. Vlodavsky, and B. Brenner Involvement of Heparanase in early pregnancy losses Thromb Res. 125 2010 e251 e257
5. A. Aharon, and B. Brenner Microparticles and pregnancy complications Thromb Res. 127 Suppl. 3 2011 S67 S71
6. M.H. Bouvier-Colle, M. Saucedo, C. Deneux-Tharaux Le CNEMM The confidential enquiries into maternal deaths, 1996-2006 in France: what consequences for the obstetrical care? J Gynecol Obstet Biol Reprod (Paris). 2011
7. A.F. Jacobsen, F.E. Skjeldestad, and P.M. Sandset Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium - a register-based case-control study Am J Obstet Gynecol. 198 2008 233.e1-7
8. A.F. Jacobsen, F.E. Skjeldestad, and P.M. Sandset Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study J Thromb Haemost. 6 2008 905 912
9. S.M. Bates, I.A. Greer, I. Pabinger, S. Sofaer, J. Hirsh American College of Chest Physicians Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest. 133 2008 844S 886S
10. A.J. Duhl, M.J. Paidas, S.H. Ural, W. Branch, H. Casele, and J. Cox-Gill Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes Am J Obstet Gynecol. 197 2007 457.e1-21
11. P. Clark Maternal venous thrombosis Eur J Obstet Gynecol Reprod Biol. 139 2008 3 10
12. J.G. Ray, and W.S. Chan Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation Obstet Gynecol Surv. 54 1999 265 271
13. E.R. Pomp, A.M. Lenselink, F.R. Rosendaal, and C.J.M. Doggen Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study J Thromb Haemost. 6 2008 632 637
14. I. Pabinger, H. Grafenhofer, P.A. Kyrle, P. Quehenberger, C. Mannhalter, and K. Lechner Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism Blood. 100 2002 1060 1062
15. J.A. Heit, C.E. Kobbervig, A.H. James, T.M. Petterson, K.R. Bailey, and L.J. Melton Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study Ann Intern Med. 143 2005 697 706
16. J.M. Morris, C.S. Algert, and C.L. Roberts Incidence and risk factors for pulmonary embolism in the postpartum period J Thromb Haemost. 8 2010 998 1003
17. E.L. Simpson, R.A. Lawrenson, A.L. Nightingale, and R.D. Farmer Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database BJOG 108 2001 56 60
18. A.H. James, M.G. Jamison, L.R. Brancazio, and E.R. Myers Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality Am J Obstet Gynecol. 194 2006 1311 1315
19. M.D. McColl, J.E. Ramsay, R.C. Tait, I.D. Walker, F. McCall, and J.A. Conkie Risk factors for pregnancy associated venous thromboembolism Thromb Haemost. 78 1997 1183 1188
20. S.M. Bates Management of pregnant women with thrombophilia or a history of venous thromboembolism Hematology Am Soc Hematol Educ Program. 2007 2007 143 150
21. P.G. Lindqvist, M. Kublikas, and B. Dahlbäck Individual risk assessment of thrombosis in pregnancy Acta Obstet Gynecol Scand. 81 2002 412 416
22. S. Noboa, G. Le Gal, K. Lacut, B. Mercier, C. Leroyer, and E. Nowak Family history as a risk factor for venous thromboembolism Thromb Res. 122 2008 624 629
23. I.A. Greer Inherited thrombophilia and venous thromboembolism Baillieres Best Pract Res Clin Obstet Gynaecol. 17 2003 413 425
24. S.M. Nelson, and I.A. Greer Thrombophilia and the risk for venous thromboembolism during pregnancy, delivery, and puerperium Obstet Gynecol Clin North Am. 33 2006 413 427
25. A. Eldor, and Thrombophilia thrombosis and pregnancy Thromb Haemost. 86 2001 104 111
26. M.D. McColl, I.D. Walker, and I.A. Greer The role of inherited thrombophilia in venous thromboembolism associated with pregnancy Br J Obstet Gynaecol. 106 1999 756 766
27. L. Robertson, O. Wu, P. Langhorne, S. Twaddle, P. Clark, and G.D.O. Lowe Thrombophilia in pregnancy: a systematic review Br J Haematol. 132 2006 171 196
28. J.G. Ray, D. Shmorgun, and W.S. Chan Common C677T polymorphism of the methylenetetrahydrofolate reductase gene and the risk of venous thromboembolism: meta-analysis of 31 studies Pathophysiol Haemost Thromb. 32 2002 51 58
29. G. Ruiz-Irastorza, M. Crowther, W. Branch, and M.A. Khamashta Antiphospholipid syndrome Lancet. 376 2010 1498 1509
30. W. Lim, M.A. Crowther, and J.W. Eikelboom Management of antiphospholipid antibody syndrome: a systematic review JAMA. 295 2006 1050 1057
31. M. Empson, M. Lassere, J. Craig, and J. Scott Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant Cochrane Database Syst Rev. 2005 CD002859
32. M. Galli, D. Luciani, G. Bertolini, and T. Barbui Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature Blood. 101 2003 1827 1832
33. M. Galli, D. Luciani, G. Bertolini, and T. Barbui Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome Blood. 102 2003 2717 2723
34. M.J. Paidas, D.H.W. Ku, J. Langhoff-Roos, and Y.S. Arkel Inherited thrombophilias and adverse pregnancy outcome: screening and management Semin Perinatol. 29 2005 150 163
35. L. Duley, D.J. Henderson-Smart, S. Meher, and J.F. King Antiplatelet agents for preventing pre-eclampsia and its complications Cochrane Database Syst Rev 2007 CD004659
36. D.A. Savitz, I. Hertz-Picciotto, C. Poole, and A.F. Olshan Epidemiologic measures of the course and outcome of pregnancy Epidemiol Rev. 24 2002 91 101
37. M.A. Rodger, M. Paidas, C. McLintock, M. Claire, S. Middeldorp, and S. Kahn Inherited thrombophilia and pregnancy complications revisited Obstet Gynecol. 112 2008 320 324
38. D. Getahun, C.V. Ananth, and W.L. Kinzler Risk factors for antepartum and intrapartum stillbirth: a population-based study Am J Obstet Gynecol. 196 2007 499 507
39. R.B. Ness, J. Zhang, D. Bass, and M.A. Klebanoff Interactions between smoking and weight in pregnancies complicated by preeclampsia and small-for-gestational-age birth Am J Epidemiol. 168 2008 427 433
40. C.V. Ananth, M.R. Peltier, M.R. Chavez, R.S. Kirby, D. Getahun, and A.M. Vintzileos Recurrence of ischemic placental disease Obstet Gynecol. 110 2007 128 133
41. R.A. Odegård, L.J. Vatten, S.T. Nilsen, K.A. Salvesen, and R. Austgulen Risk factors and clinical manifestations of pre-eclampsia BJOG 107 2000 1410 1416
42. P. Merviel, L. Touzart, V. Deslandes, M. Delmas, M. Coicaud, and J. Gondry Risk factors of preeclampsia in single pregnancy J Gynecol Obstet Biol Reprod (Paris). 37 2008 477 482
43. M.A. Rodger, M.T. Betancourt, P. Clark, P.G. Lindqvist, D. Dizon-Townson, and J. Said The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies PLoS Med. 7 2010 e1000292
44. E. Rey, S.R. Kahn, M. David, and I. Shrier Thrombophilic disorders and fetal loss: a meta-analysis Lancet. 361 2003 901 908
45. H.E.A. Howley, M. Walker, and M.A. Rodger A systematic review of the association between factor V Leiden or prothrombin gene variant and intrauterine growth restriction Am J Obstet Gynecol. 192 2005 694 708
46. M.J. Cuadrado, and M.A. Khamashta The anti-phospholipid antibody syndrome (Hughes syndrome): therapeutic aspects Baillieres Best Pract Res Clin Rheumatol. 14 2000 151 163
47. L.M. Askie, L. Duley, D.J. Henderson-Smart, L.A. Stewart PARIS Collaborative Group Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data Lancet. 369 2007 1791 1798
48. A.J. Butwick, and B. Carvalho Neuraxial anesthesia in obstetric patients receiving anticoagulant and antithrombotic drugs Int J Obstet Anesth. 19 2010 193 201
49. I.A. Greer Anticoagulants in pregnancy J Thromb Thrombolysis. 21 2006 57 65
50. I.A. Greer, and C. Nelson-Piercy Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy Blood. 106 2005 401 407
51. H. Keïta-Meyer, V. Faitot Comité douleur et anesthésie Loco-Régionale de la SFAR Analgesia in particular situation: pregnant woman Ann Fr Anesth Reanim. 26 2007 1020 1023
52. J. Wesseling, D. Van Driel, H.S. Heymans, F.R. Rosendaal, L.M. Geven-Boere, and M. Smrkovsky Coumarins during pregnancy: long-term effects on growth and development of school-age children Thromb Haemost. 85 2001 609 613
53. A. Gerhardt, R.B. Zotz, M. Stockschlaeder, and R.E. Scharf Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids Thromb Haemost. 97 2007 496 497
54. M.L. Chapman, A.R. Martinez-Borges, and H.L. Mertz Lepirudin for treatment of acute thrombosis during pregnancy Obstet Gynecol. 112 2008 432 433
55. Conférence de consensus Recommandations pour la pratique clinique de la Société Française d'Anesthésie et de Réanimation : prévention de la maladie thromboembolique veineuse périopératoire et obstétricale. ANAES 2005.
56. Thomson A, Greer I. Thromboembolic disease in pregnancy-green-top No. 28 February -Version. Guideline No. 28 1 of 17 Thromboembolic disease in pregnancy Advances in low molecular weight. 2007.
57. C. Chauleur, C. Vieira, and P. Seffert Prophylaxis of thromboembolic disease in obstetrics after the French guidelines publication Gynecol Obstet Fertil. 36 2008 23 34
58. R.M. Bauersachs, J. Dudenhausen, A. Faridi, T. Fischer, S. Fung, and U. Geisen Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women Thromb Haemost. 98 2007 1237 1245
59. Y. Dargaud, L. Rugeri, J. Ninet, C. Negrier, and M.C. Trzeciak Management of pregnant women with increased risk of venous thrombosis Int J Gynaecol Obstet. 90 2005 203 207
60. G. Sarig, G. Vidergor, and B. Brenner Assessment and management of high-risk pregnancies in women with thrombophilia Blood Rev. 23 2009 143 147
61. N. Weiss, and P.S. Bernstein Risk factor scoring for predicting venous thromboembolism in obstetric patients Am J Obstet Gynecol. 182 2000 1073 1075
62. C. Chauleur, J.C. Gris, S. Laporte, F. Rancon, M.N. Varlet, and H. Decousus Use of the Delphi method to facilitate antithrombotics prescription during pregnancy Thromb Res. 126 2010 88 92